Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characteristics of Triple-Negative Breast Cancer in Patients With a <i>BRCA1</i> Mutation: Results From a Population-Based Study of Young Women

18 Oct 2011

Abstract excerpt

PURPOSE: Triple-negative breast cancers (TNBCs) are tumors with low or no expression of estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. These tumors have a poor prognosis, remain a clinical challenge, and are more common among women with BRCA1 mutations. We tested whether there are distinguishing features of TNBC after BRCA1 mutation status has been taken into account....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Breast Cancer Treatment Studies
Share to Cancer Risks and Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22010008
DOI: 10.1200/jco.2010.33.6446

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characteristics of Triple-Negative Breast Cancer in Patients With a <i>BRCA1</i> Mutation: Results From a Population-Based Study of Young WomenPMID 22010008Read ↗

Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.Semantic proximity Read ↗

Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.Semantic proximity Read ↗

HER‐2/<i>neu</i> status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer RegistrySemantic proximity Read ↗

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.Semantic proximity Read ↗

BRCA1/2 mutations and triple negative breast cancers.Semantic proximity Read ↗

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.Semantic proximity Read ↗

Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.Semantic proximity Read ↗

[GENOTYPE-PHENOTYPE CORRELATIONS BY SPECIFIC FOUNDER VARIANTS IN BRCA IN ISRAELI WOMEN].Semantic proximity Read ↗

Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.Semantic proximity Read ↗

Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers.Semantic proximity Read ↗

Effect of BRCA germline mutations on breast cancer prognosisSemantic proximity Read ↗

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.